Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020–2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality
Abstract Background The o severe acute respiratory coronavirus 2 (SARS-CoV-2) pandemic has killed millions of people and caused widespread concern around the world. Multiple genetic variants of SARS-CoV-2 have been identified as the pandemic continues. Concerns have been raised about high transmissi...
Main Authors: | Amr Kandeel, Yassmin Moatasim, Manal Fahim, Hala Bahaaeldin, Rabeh El-Shesheny, Wael H. Roshdy, Mina N. Kamel, Shaymaa Shawky, Mokhtar Gomaa, Amel Naguib, Nancy El Guindy, Ola Deghedy, Reham Kamel, Mohamed Khalifa, Ramy Galal, Mohamed Hassany, Galal Mahmoud, Ahmed Kandeil, Salma Afifi, Amira Mohsen, Mohammad Abdel Fattah, Ghazi Kayali, Mohamed A. Ali, Khaled Abdelghaffar |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-08-01
|
Series: | BMC Infectious Diseases |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12879-023-08527-y |
Similar Items
-
SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation
by: Nancy Fayad, et al.
Published: (2021-06-01) -
Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021
by: Wael H. Roshdy, et al.
Published: (2022-07-01) -
EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2.
by: Wael H Roshdy, et al.
Published: (2020-01-01) -
EGYVIR: An immunomodulatory herbal extract with potent antiviral activity against SARS-CoV-2
by: Wael H. Roshdy, et al.
Published: (2020-01-01) -
Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2.
by: Ahmed Kandeil, et al.
Published: (2020-01-01)